Multitargeted therapy of cancer by ellagitannins

被引:176
作者
Heber, David [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Ctr Human Nutr, Los Angeles, CA 90095 USA
关键词
Pomegranate; Ellagitannins; Prostate cancer; Urolithins;
D O I
10.1016/j.canlet.2008.03.043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ellagitannins are bioactive polyphenols that have antioxidant and anti-inflammatory bioactivities. Pomegranate juice has the highest concentration of ellagitannins of any commonly consumed juice and contains the unique ellagitannin, punicalagin. Punicalagin is the largest molecular weight polyphenol known. Ellagitannins are not absorbed intact into the blood stream but are hydrolyzed to ellagic acid. They are also metabolized by gut flora into urolithins which are conjugated in the liver and excreted in the urine. These urolithins are also bioactive and inhibit prostate cancer cell growth. Inhibition of Nuclear Factor Kappa-B activation has been shown in prostate cancer cells and in human prostate cancer xenografts in mice. In clinical studies, pomegranate juice administration led to a decrease in the rate of rise of Prostate Specific Antigen after primary treatment with surgery or radiation. Continued translational research on the chemopreventive potential of pomegranate ellagitannins is ongoing. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:262 / 268
页数:7
相关论文
共 42 条
[1]   Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells [J].
Adams, LS ;
Seeram, NP ;
Aggarwal, BB ;
Takada, Y ;
Sand, D ;
Heber, D .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2006, 54 (03) :980-985
[2]   Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-κB pathways and inhibits skin tumorigenesis in CD-1 mice [J].
Afaq, F ;
Saleem, M ;
Krueger, CG ;
Reed, JD ;
Mukhtar, H .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (03) :423-433
[3]   Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells [J].
Albrecht, M ;
Jiang, WG ;
Kumi-Diaka, J ;
Lansky, EP ;
Gommersall, LM ;
Patel, A ;
Mansel, RE ;
Neeman, I ;
Geldof, AA ;
Campbell, MJ .
JOURNAL OF MEDICINAL FOOD, 2004, 7 (03) :274-283
[4]  
Allison A C, 1997, Adv Pharmacol, V38, P273
[5]   High-performance liquid chromatographic determination with photodiode array detection of ellagic acid in fresh and processed fruits [J].
Amakura, Y ;
Okada, M ;
Tsuji, S ;
Tonogai, Y .
JOURNAL OF CHROMATOGRAPHY A, 2000, 896 (1-2) :87-93
[6]   Epidermal growth factor-induced nuclear factor κB activation:: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells [J].
Biswas, DK ;
Cruz, AP ;
Gansberger, E ;
Pardee, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) :8542-8547
[7]  
Castonguay A, 1997, INT J ONCOL, V10, P367
[8]   The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans [J].
Cerdá, B ;
Espín, JC ;
Parra, S ;
Martínez, P ;
Tomás-Barberán, FA .
EUROPEAN JOURNAL OF NUTRITION, 2004, 43 (04) :205-220
[9]   Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice [J].
Cerdá, B ;
Llorach, R ;
Cerón, JJ ;
Espín, JC ;
Tomás-Barberán, FA .
EUROPEAN JOURNAL OF NUTRITION, 2003, 42 (01) :18-28
[10]  
Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt